irbesartan (Q947266)

imported from Wikimedia project

17 November 2015

Irbesartan polymorph A.svg
366 × 282; 30 KB

1 reference

German Wikipedia

mass

428.23246 dalton

1 reference

138402-11-6 (English)

4 October 2016

chemical formula

C₂₅H₂₈N₆O

1 reference

138402-11-6 (English)

19 November 2016

canonical SMILES

CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5

1 reference

138402-11-6 (English)

19 November 2016

defined daily dose

0.15 gram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=C09CA04

active ingredient in

Aprovel

1 reference

EMEA/H/C/000141

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000141/human_med_000649.jsp

22 March 2017

Irbesartan Bms

1 reference

EMEA/H/C/000786

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000786/human_med_000851.jsp

22 March 2017

Irbesartan Teva

1 reference

EMEA/H/C/001093

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001093/human_med_000855.jsp

22 March 2017

Irbesartan Zentiva

1 reference

EMEA/H/C/000785

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000785/human_med_000856.jsp

22 March 2017

Karvea

1 reference

EMEA/H/C/000142

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000142/human_med_000868.jsp

22 March 2017

Sabervel

1 reference

EMEA/H/C/002510

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002510/human_med_001556.jsp

22 March 2017

1 reference

14 February 2018

World Health Organisation international non-proprietary name

irbesartan (English)

1 reference

irbesartan (English)

medical condition treated

4 October 2016

arterial hypertension

2 references

13 December 2016

Drug Indications Extracted from FAERS

significant drug interaction

2 October 2018

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimethoprim

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamterene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiloride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

angiotensin II receptor type 1

subject has role

antagonist

1 reference

Solute carrier family 10 member 1

17 August 2016

subject has role

antagonist

1 reference

17 August 2016

legal status (medicine)

boxed warning

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

Australian pregnancy category D

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category C

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Irbesartan

last update

13 January 2017

subject has role

angiotensin II receptor antagonist

1 reference

Medical Subject Headings

MeSH descriptor ID

C081309

15 March 2018

antihypertensive drug

1 reference

InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)

Medical Subject Headings

15 March 2018

Irbesartan

0 references

Identifiers

InChI

1 reference

138402-11-6 (English)

19 November 2016

2 references

138402-11-6 (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

138402-11-6

2 references

irbesartan (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=138402-11-6

10 April 2021

1 reference

Irbesartan (English)

19 November 2016

2 references

138402-11-6 (English)

19 November 2016

Reaxys registry number

6620400

1 reference

irbesartan (English)

4 October 2016

mapping relation type

2 references

IRBESARTAN (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)

1 reference

IRBESARTAN (English)

19 November 2016

2 references

inferred from InChIKey

SCHEMBL285754

2 references

based on heuristic

inferred from InChIKey

MSBNK-Athens_Univ-AU209402

1 reference

MassBank accession ID

SM818701

0 references

SM818756

0 references

0 references

MSBNK-Athens_Univ-AU209403

0 references

MSBNK-Athens_Univ-AU209404

0 references

MSBNK-Athens_Univ-AU209405

0 references

MSBNK-Athens_Univ-AU209407

0 references

MSBNK-Athens_Univ-AU209408

0 references

MSBNK-Athens_Univ-AU209409

0 references

MSBNK-Athens_Univ-AU209410

0 references

MSBNK-Athens_Univ-AU209411

0 references

MSBNK-Athens_Univ-AU209451

0 references

MSBNK-Athens_Univ-AU209452

0 references

MSBNK-Athens_Univ-AU209453

0 references

MSBNK-Athens_Univ-AU209454

0 references

MSBNK-Athens_Univ-AU209455

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-Waters-WA001036

0 references

MSBNK-Waters-WA001037

0 references

MSBNK-Waters-WA001038

0 references

MSBNK-Waters-WA001039

0 references

MSBNK-Waters-WA001040

0 references

MSBNK-Waters-WA001041

0 references

MSBNK-Waters-WA001042

0 references

SPLASH

splash10-0a4i-0190000000-97e745948e54828d3cb9

0 references

splash10-0a4i-0190000000-da94b482f79a90e5784c

0 references

splash10-0a4i-0590000000-122d562d8d5352dd2a88

0 references

splash10-004i-0000900000-b6619e18dca63147588d

0 references

splash10-004l-0801900000-b884691a3577ffab749f

0 references

splash10-0006-0900000000-130056acf88b6caed131

0 references

splash10-0006-0900000000-97919ed4377a869dc8cc

0 references

splash10-0006-0900000000-55cf0ae2c686af5c38e3

0 references

splash10-0a4i-0290100000-e3c8e0950f0290ccefdc

0 references

splash10-004i-0000900000-61da6c552b6d170d8283

0 references

splash10-0a4i-0290100000-0e7bf8c50467ae6a7604

0 references

splash10-0a4i-0290000000-21c875faccf2cb3a15b3

0 references

splash10-0a4i-0490000000-e7c75f4866b7b9f0d0e8

0 references

splash10-0a59-1960000000-a6601ea10b0fe87e6c0a

0 references

splash10-0a5c-0920000000-d7f5d3920f8586eac33f

0 references

splash10-004i-0000900000-57215a52cacf3c9ede5c

0 references

splash10-0a4i-0290100000-29a34a51d9b42976905f

0 references

splash10-0a4i-0290000000-e6e7f5d1e696ec43651d

0 references

splash10-0a4i-1690000000-217de4040066a20fd367

0 references

splash10-0a59-1950000000-ac722925e6b2aa2930fb

0 references

splash10-0a5c-0930000000-0b8d8a97e3db30de0e21

0 references

splash10-0a4i-0290100000-ee3d21bc8110bf939cdd

0 references

splash10-0007-0908000000-0c994ee86857e7d63e48

0 references

splash10-004i-0000900000-b610a12a9852ff1a11c1

0 references

splash10-0006-0900100000-c9024d0b00a0ec781fa2

0 references

splash10-0006-0900000000-cb54b7c0917d67313110

0 references

splash10-0006-0900000000-4e0d1ebbc0609ecaa59d

0 references

splash10-0006-0900000000-ec0fc575bb22a99c258d

0 references

splash10-00di-0900000000-f1f0658a24e5097674e0

0 references

splash10-004i-0000900000-12da76073bae1768b7e2

0 references

splash10-0006-0900000000-cce4e6a8c5bbaa66c902

0 references

splash10-0006-0900000000-c7202e4de31fc762cf2d

0 references

splash10-0006-0900000000-ad31324f1b1a0e9be0b8

0 references

splash10-0006-0900000000-2301c02c521c3dab9c79

0 references

splash10-00di-0900000000-8b6e9e772c5af1365e87

0 references

splash10-0007-0908000000-97706153fba817a654e4

0 references

splash10-0a59-2791700000-a5bc1c8b020f7731fb1e

0 references

splash10-0a6r-0490500000-2693358cc0b819b773a5

0 references

splash10-002f-0900400000-f9f11306595c7a9de207

0 references

HSDB ID

8215

1 reference

Hazardous Substances Data Bank

28 October 2019

Irbesartan (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.119.966

27 December 2018

ECHA Substance Infocard ID

2-butyl-3-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one (English)

quotation

CAS no.: 138402-11-6 (English)

100.119.966

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.119.966

27 December 2018

2-butyl-3-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one (English)

quotation

CAS no.: 138402-11-6 (English)

1 reference

Irbesartan (English)

publication date

17 November 2015

1 reference

irbesartan (English)

19 November 2016

1 reference

D02.455.426.559.389.185.413

5 February 2021

Irbesartan

0 references

MeSH tree code

0 references

0 references

0 references

0 references

1 reference

irbesartan (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0015163

2 references

based on heuristic

inferred from InChIKey

2 references

irbesartan (English)

19 November 2016

MedlinePlus drug identifier

a698009

0 references

PatientsLikeMe treatment ID

0 references

1 reference

irbesartan (English)

19 November 2016

0 references

1 reference

1 reference

irbesartan (English)

4 October 2016

1 reference

https://docs.openalex.org/download-snapshot/snapshot-data-format

irbesartan (English)

4 October 2016

0 references

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

UMLS CUI

C0288171

1 reference